ªø©°¤j¾Ç°ò¦]Âà´Þ¹«®Ö¤ß¹êÅç«Ç¨Ï¥ÎnÂI
Chang
Gung University Transgenic Mouse Core Laboratory (TMCL) Guideline
|
¹êÅç«Ç¥D«ù¤H¡G¼Ú¶§«~¥D¥ô ³sµ¸¤H¡GJ´¼°¶ 3171, 5008 |
||||||||||||||||||
|
¡@
ªA°È¶µ¥Ø¡G A.ì®ÖÅã·Lª`®g¡]Pronuclei
microinjection¡^ B.FL·F²ÓM¤§°ò¦]¼Ðªº¡]ES
cell gene targeting¡^ C.´O¦X¹«¥Í²£¡]Chimera
production¡^ D. FL§Ná¡]Embryo cryopreservation¡^ E.¿Ô¸ß¥H¤U¨Æ¶µ¡G 1. ¸üÅ餧ºc¿v¡]Gene
vector construction¡^ 2. Âà´Þ°ò¦]¸üÅéºc¿v¤Î»s³Æ¡]Preparation
of constructs¡^ 3. °ò¦]Âà´Þ¤p¹«¤Î°ò¦]¼Ðªº¤p¹«¤§¹}¨|¤ÎÁc´Þ¡]Maintenance
of transgenic/ gene-targeted mouse lines¡^ 4.
°ò¦]Âà´Þ¤p¹«¤Î°ò¦]¼ÐªºES
cell Ų§O¡]Identification of
transgenic founder mice and correctly targeted ES clones¡^ ¤£´£¨Ñ¥H¤UªA°È¶µ¥Ø A.¸üÅé¤ÎÂà´Þ°ò¦]¤§´£¨Ñ¤Î¨ä»s³Æ B.°ò¦]Âà´Þ¤p¹«¤§Å²§O C.°ò¦]¼ÐªºES
cell¤§Å²§O D.°ò¦]Âà´Þ¤p¹«¤Î°ò¦]¼Ðªº¤p¹««~¨t¤§¥N¾i¤ÎÁc´Þ E.Ó®×µ²§ô«á¤§¤p¹«FLÀx¦s ¨Ï¥Î³W«h A. °ò¦]Âà´Þ¹«®Ö¤ß¹êÅç«Ç¡]Transgenic
Mouse Core Laboratory¡^¥H¤U²ºÙTMCL¡A±N±q10/1/2002°_±µ¨üªø©°¨t²Î¤§©e°U¡A¥Í²£°ò¦]Âà´Þ¤Î°ò¦]¼Ðªº¤p¹«¤Î´£¨Ñ¨ä¥¦¬ÛÃöªA°È¡C B. TMCL¤§¦¬¶O±N¥Ñªø©°°ò¦]Âà´Þ¹«¨Ï¥Î©eû·|¡]Chang Gung Transgenic Mouse Use Committee¡^°Q½×¨M©w¡A¨ÃÀH®Éµø»Ýn¥Ñ©eû·|ק蠟¡C C. ©e°UӮר̦¬¥ó¤é´Á¥ý«á¶¶§Ç¤Î¼Æ¶q¬°Ó®×¶i¦æ¥ý«á¤§¨Ì¾Ú¡F¦P¤@¥Ó½Ð¤H´£¥X¤@Ó¥H¤W¤§Ó®×¥Ó½Ð¡AY¤§«á¦³¨ä¥¦¥Ó½ÐӮ׫h¥H¬ï´¡¤è¦¡¶i¦æ¡C¦¬¨ì¥Ó½Ðªí«áTMCL¤Hû·|»P¥Ó½Ð¤H°µ¶i¤@¨Bªº½T»{¡CY¦³¨ä¥¦¨Ò¥~¨Æ¶µ¡A»Ý½Õ°Ê¶i¦æ¤§¶¶§Ç®É¡A«h¥Ñ©eû·|¨ó½Õ«á¨M©w¡C D. Âà´Þ°ò¦]¤§¨Ó·½¡BI´º¡BÂà´Þ°ò¦]¤§ºc¿v¹ÏÃСF¥H¤Î±ýÂà´Þ°ò¦]¤§¤p¹««~¨tµ¥§¡À³¸Ô²Ó¶ñ¼g©ó¥Ó½Ðªí¤W¡A¥H§QTMCL¤Hû»P¥Ó½ÐªÌ¶¡¤§·¾³q¡C E. ¬°¼W¶iTMCL¤§°õ¦æ®Ä²v¡A¥Ó½Ð¤HÀ³¸ÔŪTMCL¤§¥Ó½Ð¶·ª¾¡AÂà´Þ°ò¦]¤§»s³Æ¥²¶·²Å¦XTMCL¤§³W©w¡CYÂà´Þ°ò¦]¤§½è»P¶q¤£²Ån¨D¡A±N¤©°h¥ó¡AÓ®×¶i¦æ¤§®Éµ{¥ç±N¦]¦¹©µ¿ð¡CY¹ð¦¸¤£²Å«h¨ú®ø©e°U¡C F. TMCL¥u¨Ï¥Î°·±dª¬ªp¨}¦n¤Î¤£±a¦³¯S©w¯fìµß¡]SPF¡^¤§°Êª«¡A¥B¹}¨|©óªø©°¹êÅç°Êª«¤¤¤ßµL¯S©w¯fì°Ï¤º¡CTMCL¤£t³dÓ®×µ²§ô«á¤§°Êª«°·±dª¬ªp¡C ¡@ ¡@ ¡@ ¡@ ¡@ ¡@ ¡@ |
||||||||||||||||||
| ¡@ | ||||||||||||||||||
|
ì®ÖÅã·Lª`®g¡]Pronuclei microinjection¡^ A.
¨Æ«e·Ç³Æ¡G¦b¥Ó½Ð°ò¦]Âà´Þ¹êÅç«e¡A¥²¶·¥ýÁA¸Ñ¥H¤U¨Æ¶µ¡C 1.¤w§¹¦¨Âà´Þ°ò¦]¤§ºc¿v¡C 2.¤w½T¥ß¦³®Ä¿z¿ïÂà´Þ°ò¦]¤§¤èªk¡C¡]¦pPCR, Southern blot¡^ 3.¦³¨¬°÷ªº°Êª«©ÐªÅ¶¡¥i¨Ñ°ò¦]Âà´Þ¤p¹«Ác´Þ¡C 4.ÁA¸Ñ°ò¦]Âà´Þ¤§¯S©Ê¡A¨Ò¦p¦³¨Ç°ò¦]¨ü©ó¨ä¦ÛµM¯S©Ê¡AµLªkÀò±o°ò¦]Âà´Þ¤p¹«¡C B.
¤p¹««~¨t¡GTMCL´£¨Ñ¯Â«~¨tFVB/N¤Î¯Â«~¨tC57/B6¤p¹«¬°¥Dn¹ï¶H¡C¨ä¥¦«~¨t«h¼È¤£´£¨Ñ¡C C.
¤wºc¿v§¹¦¨¤§½èÅ饲¶·¥i¥H§Q¥Î±`¥Îªº¨îúA»Ã¯À³B²z«á¡A¤À¦¨Âà´Þ°ò¦]¤Î¸üÅéµ¥¨âÓ¥H¤W¤§¤ù¬q¡C¬°Á×§K¦U¤ù¬q¶¡¤§¦Ã¬V¡A¨C¤@¤ù¬q¥²¶·¬Û®t1Kb¥H¤W D.
¬°¨Ï°ò¦]Âà´Þ¤§®Ä²v´£°ª¡A¥H¤U´XÂI½Ð¿í¦u¡G 1.
»s³Æ§¹¦¨¤§Âà´Þ°ò¦]½èÅéÀx¦s¡A¤£¥i¶W¹L¨â¶g¥H¤W¡C 2.
ºc¿v§¹¦¨¤§½èÅé½Ð¤Å¥ý¦æ¥H¨îúA»Ã¯À³B²z«áÀx¦s¡A«ÝTMCL¤Hû³qª¾«á¦A¦æ³B²z¡C 3.
³B²z§¹¦¨¤§½èÅ饲¶·¦b10£gg¥H¤W¡AÅé¿n¤£¶W¹L100£gl¡C°e¥æDNA®É¥²¶·ªþ¤W¹qªa¹Ï¡A²M·¡¼Ð¥Ü±ýÂà´Þ°ò¦]¤§¤ù¬q¡C 4.
°e¥æDNA®É¥²¶·¶ñ¼g¹ê»Ú¤§¿@«×¡A¨Ã´£¨Ñ¥iÃÒ©ú¤§¸ê®Æ¡C¡]¦pO.D. ¤Î¥i©wDNA¿@«×¤§¹qªa¹Ï¡^ 5.
¥H¨îúA»Ã¯À³B²z§¹¦¨¤§DNA¥²¶·ºI¤Á§¹¥þ¤ÏÀ³¡A§_«hTMCL±o¤©¥H°h¥ó¡C E.
¨C¤@Ó®×±N¦Ü¤Ö´£¨Ñ¤°¦±a¦³Âà´Þ°ò¦]¤§¤p¹«¡AY¦P¤@Âà´Þ°ò¦]n¨D§ó¦h¤§°ò¦]Âà´Þ¤p¹«À³µø¬°¥t¤@Ó·sӮסC¦bTMCL¥¿±`¤§¾Þ§@µ{§Ç¤U¡AY¦]¤£¥i§Ü¤O¤§¦]¯À¦ÓµL°ò¦]Âà´Þ¤p¹«©Î¼Æ¶q¤£¨¬¡ATMCL±N«°µ¤@¦¸¡Aº¸«áµ²§ô¦¹¤@ӮסC F.
¶i¦æª`®g«á¤Ó¬P´Á¡ATMCL±N³qª¾¥Ó½ÐªÌ¨ú¦^¤p¹«§À¤Ú¡C¥Ó½Ð¤H¥²¶·¦b¤@Ó¬P´Á¤º¦^ÂШêþ¤W¿z¿ïµ²ªG¡A»â¦^¤p¹«¡C
G.
TMCL¤£t³d°ò¦]Âà´Þ¤p¹««áÄò¤§¥N¾i¤ÎÁc´Þ¡C H.
©Ò¦³¥Ó½Ð®É©Ò»Ý¶ñ¤§ªí®æ¡A§¡À³¸Ô²Ó¶ñ¼g¡CY¦³¶ñ¼g¤£²M¤§³B¡AÀ³¤©¸É¤W«á¤~§¹¦¨¥Ó½Ð¡C¦bÓ®×¶i¦æ¤¤»Ý¶ñ¼g¤§ªí®æ¡A¥ç»Ý¤@¤@¸Ô²Ó¶ñ¼g¡C¦@¦³¥H¤Uªí®æ»Ý¶ñ¼g¡G N0.1 Pronuclei
microinjection order form¡Ð¥Ó½Ð®É N0.2
Prescreen confirmation form¡Ð¥Ó½Ð®É N0.3
DNA material condition form¡Ð°e¥æDNA®É N0.4
Tail sample release form¡Ð¨ú¦^§À¤Ú®É N0.5
Animal release form¡Ð»â¦^°Êª«®É I.
¦¬¶O¼Ð·Ç 1.
2.
Ó®×¶}©l¶i¦æ®É§Y¦æ¦¬¶O¡C 3. ©eû·|±oµø¹ê»Ú±¡ªp½Õ¾ã¦¬¶O¡C ¡@ ¡@ ¡@ ¡@ |
||||||||||||||||||
| ¡@ | ||||||||||||||||||
|
FL·F²ÓM°ò¦]¼Ðªº¡]ES cell gene targeting¡^
A. ¨Æ«e·Ç³Æ¡G¦b¥Ó½Ð°ò¦]Âà´Þ¹êÅç«e¡A¥²¶·¥ýÁA¸Ñ¥H¤U¨Æ¶µ¡C
1.
¥Ó½Ð«e¤w§¹¦¨ºc¿vÂà´Þ°ò¦]¡C
2.
¤w½T¥ß°ò¦]«¬Å²§O¤èªk¡A¥]¬ALong ArmºÝ¤ÎShort
ArmºÝªºÅ²§O¡C
3.
ÁA¸Ñ°ò¦]¼Ðªº¹êÅ礧°ò¥»©Ê½è¡C¨Ò¦p¦³¬Y¨Ç°ò¦]¨ü¨ä¦ÛµM¨î·|±N°§C¦¹¤@¹êÅ礧¦¨¥\¾÷²v¡C B.
TMCL¨Ï¥Î129/SvJ or R1 «~¨t¤§ES
cell¡C¦]¦¹ºc¿v°ò¦]®É¥²¶·¨Ï¥Î¦P·½°ò¦]¨Ó¶i¦æ¹êÅç¡C C.
¬°ºû«ùES
cell¤§«~½è¡ATMCL±N¨Ï¥Î¥H¤U¤§³W«h¾Þ§@ 1.¨C¤@¦¸Âà¬V¡]Transfection¡^TMCL¨Ï¥Î¦Ü¤Ö6¡Ñ106 ES cell¡C 2.±ý¶i¦æ¹êÅ礧DNA¥²¶·¦³100£gg¥H¤W¡AÅé¿n¤p©ó400£gl¡A¥B¦b³Ìªñ¨â¶g¤º»s³Æ¡C¥H³æ¤@¨îúA³B²z¨Ï¨äª½½u¤Æ§Y¥i¡C 3.°ò¦]¼Ðªº¹êÅç·|¦]±ý³B²z¤§°ò¦]¡Bºc¿v°ò¦]¤§³]p¡B¿ï´Þ°ò¦]ªº¿ï¾Üµ¥µ¥¦]¯À¼vÅT¡C¨Ï±o¨ì¥¿½T¤§ES cell¾÷²v¦³«Ü¤jªºÅܤơ]±q30-200¿¡^¡A¤@¯ë¨Ó»¡³æ¤@¿z¿ïÃĪ«¥i¥HÀò±o200-300Ó¥H¤Wªº²ÓM®è¡C¦]¦¹TMCL¦b¨C¤@¦¸¹êÅ礤·|¨Ï¥Î¤@¤p³¡¤À²ÓM¥Î©ó¹ï·Ó²Õ¡]¥u¶i¦æ³æ¤@¿z¿ï¡^¡C D.
¦b¥H¤U±¡ªp¤UTMCL±N¦A¶i¦æ§K¶O¤§²Ä¤G¦¸¹êÅç¡C 1.Y²Ä¤@¦¸¹êÅçµL¦¨¥\¼Ðªº¤§²ÓM®è¡C 2.²Ä¤@¦¸¹êÅç©ÒÀò±o¤§²ÓM®è¦b100Ó¥H¤U¡A¥B¨S¦³¨âÓ¥H¤W¦¨¥\¼Ðªº¤§²ÓM®è¡CTMCL±N¨Ï¥Î¨â¿¤§²ÓM¼Æ¡]12¡Ñ106¡^¨Ó¶i¦æ²Ä¤G¦¸¹êÅç¡C °£¦¹¤§¥~¡AY¥Ó½ÐªÌn±o¨ì§ó¦hªº²ÓM®è¡A±Nµø¬°¥t¤@Ó·sӮסC E.
¥¿½Tªº¿z¿ïµ²ªG¥²¶·¦b¦¬¨ìES cell genome DNA«á¤@Ó¤ë¦^ÂСC H.
©Ò¦³¥Ó½Ð®É©Ò»Ý¶ñ¤§ªí®æ¡A§¡À³¸Ô²Ó¶ñ¼g¡CY¦³¶ñ¼g¤£²M¤§³B¡AÀ³¤©¸É¤W«á¤~§¹¦¨¥Ó½Ð¡C¦bÓ®×¶i¦æ¤¤»Ý¶ñ¼g¤§ªí®æ¡A¥ç»Ý¤@¤@¸Ô²Ó¶ñ¼g¡C¦@¦³¥H¤Uªí®æ»Ý¶ñ¼g¡G No.6 Gene
Targeting order form¡Ð¥Ó½Ð®É No.2 Prescreen confirmation form¡Ð¥Ó½Ð®É No.3
DNA material condition form¡Ð°e¥æDNA®É No.7
ES cell genome DNA/ES cell release form¡Ð¨ú¦^ES cell ©ÎES
cell genome DNA(gDNA)®É No.8
Screening result form¡Ð¦^Âе²ªG®É G.¦¬¶O¡G 1.
2.Ó®×¶}©l¶i¦æ®É§Y¦æ¦¬¶O¡C 3.©eû·|±oµø¹ê»Ú±¡ªp½Õ¾ã¦¬¶O¡C ¡@ ¡@ |
||||||||||||||||||
| ¡@ | ||||||||||||||||||
|
´O¦X¹«¥Í²£¡]Chimera production¡^ A. ¨Æ«e·Ç³Æ¡G¦b¥Ó½Ð°ò¦]Âà´Þ¹êÅç«e¡A¥²¶·¥ýÁA¸Ñ¥H¤U¨Æ¶µ¡C 1.
¥Ó½Ð«e¤wŲ§O¦¨¥\¼Ðªº¤§ES cell®è¡C 2.
¤w§ä¥X°ò¦]«¬Å²§O¤èªk¡C 3.
¦³¨¬°÷ªº°Êª«©ÐªÅ¶¡¥i¨Ñ´O¦X¹«¤§°tºØ¡C 4.
ÁA¸Ñ¤£¬O¨C¤@°¦´O¦X¹«³£¥i¥H±N¼Ðªº°ò¦]¿ò¶Çµ¹«á¥N¡C 5.
¥Ó½ÐªÌ¦³¸q°È§iª¾TMCL¨ä´O¦X¹«¬O§_±N¼Ðªº°ò¦]¿ò¶Ç¦Ü«á¥N¡C B.
TMCL¨Ï¥ÎÅnFÅã·Lª`®g¡]Blastocyst microinjection¡^¨Ó¥Í²£´O¦X¹«¡ATMCL¥u±µ¨ü¥ÑTMCL©Ò²£¥Í¤§ES cell¨Ó¶i¦æÅã·Lª`®g¡CY¥Ó½ÐªÌ¤w±NES
cell»â¦^¥ç¤£±µ¨ü¡C C.
TMCL¨Ï¥ÎC57BL/6¤§ÅnF¶i¦æ¹êÅç¡C D.
TMCL¥H¥~ªí¤§¤ò¥ÖÃC¦â§@¬°´O¦Xµ{«×¡]Chimerism¡^¤§¨Ì¾Ú¡CTMCL±µ¨üªº¨C¤@Ó®×±N¦Ü¤Öµ¹¥Ó½ÐªÌ¤»°¦70¢M¤§¤½´O¦X¹«¡C¡]¨C¤@Ó®×¥]§t¨âÓ²ÓM®èª`®g¡A¦U¤T°¦¡^¡C E.
Y¦b²Ä¤@¦¸ª`®g«áµo²{´O¦Xµ{«×¤£°ª¡ATMCL±N³qª¾¥Ó½ÐªÌ°µ¥H¤U¨âªÌ¤§¤@³B²z¡C 1.TMCL±N¶i¦æ§ó¦h¤§Åã·Lª`®g¥H¹F¨ì¤»°¦70¢M¤§¤½´O¦X¹«¡C¡]¨C¤@Ó®×¥]§t¨âÓ²ÓM®èª`®g¡A¦U¤T°¦¡^ 2.¶i¦æ¥t¥~¤@Ó²ÓM®èªºª`®g¡C¡]¤£¤©¦¬¶O¡^ F.
TMCL¤£t³d´O¦X¹««áÄò¤§°tºØ¡A©Ò¦³´O¦X¹«§¡»Ý¦bÂ÷¨Å«á»â¦^¡C G.
©Ò¦³¥Ó½Ð®É©Ò»Ý¶ñ¤§ªí®æ¡A§¡À³¸Ô²Ó¶ñ¼g¡CY¦³¶ñ¼g¤£²M¤§³B¡AÀ³¤©¸É¤W«á¤~§¹¦¨¥Ó½Ð¡C¦bÓ®×¶i¦æ¤¤»Ý¶ñ¼g¤§ªí®æ¡A¥ç»Ý¤@¤@¸Ô²Ó¶ñ¼g¡C¦@¦³¥H¤Uªí®æ»Ý¶ñ¼g¡G No.9 Blastocyst microinjection order form¡Ð¥Ó½Ð®É No.5 Animal release
form¡Ð»â¦^°Êª«®É H.
¦¬¶O¡G 1.¨C¤@ÓÓ®×¥]§t¨âÓ²ÓM®èª`®g
2.Ó®×¶}©l¶i¦æ®É§Y¦æ¦¬¶O 3.©eû·|±oµø¹ê»Ú±¡ªp½Õ¾ã¦¬¶O¡C ¡@ ¡@ ¡@ ¡@ |
||||||||||||||||||
| ¡@ | ||||||||||||||||||
|
FL§Ná¡]Cryopreservation¡^ 1. ¥Ó½Ð¶·ª¾¡G ¡]1¡^ ¥²¶·¤w¦³¤Q°¦¥H¤W¥i¨Ñ°tºØªº¤½¹«¡]¤»¶g¥H¤W¡^¡C ¡]2¡^ ¤p¹«±Ú¸s¥²¶·µL¯f·½µßªº¦Ã¬V¡C 2. ¥»¤¤¤ß¨Ï¥Î¶W¯Å±Æ§Z¨ÓÀò±o¤j¶qªºFL¥H¨Ñ§Ná¡A¥Ó½ÐªÌÀ³·Ç³Æ¦n¾A·í¶gÄÖªº¤p¹«¥H¨Ñ¨Ï¥Î¡C 3. |